This study aimed at analyzing circulating levels of inflammatory and profibrogenic cytokines
in patients with hepatitis C virus (HCV) chronic infection undergoing therapy with direct …

Background: Several studies have explored the associations between interleukin-6 (IL-6)
gene polymorphisms and the susceptibility to liver diseases, however, results remain …

Hepatocellular carcinoma is a primary liver malignancy in which the risk of development is
always multifunctional. Interleukin-6 is a proinflammatory and multifunctional cytokine, which …

Background The hepatitis B virus (HBV) is one of the leading causes of acute, chronic and
occult hepatitis (OBI) representing a serious public health threat. Cytokines are known to be …

The HCV treatment with DAAs has offered a unique opportunity to analyze the changes in
the immune system caused by the rapid inhibition of viral replication. We sought to analyze …

Virological responses after hepatitis C virus (HCV) treatment may alleviate liver disease and
extra-hepatic manifestations. Our study aims to explore the impact of HCV eradication on the …

Host regulatory immune response is involved in the hepatic inflammatory process caused by
the hepatitis C virus (HCV). We aimed to determine if HCV clearance with direct-acting …

The activity of the membrane transporters organic anion‐transporting polypeptide 1B1
(OATP1B1) & breast cancer resistance protein (BCRP)(rosuvastatin) and P‐glycoprotein (P …

Polymorphisms present in the TNF promoter region has shown to influence the gene
transcription. Leprosy displays different clinical manifestations according to the immune …

This study aims to evaluate the impact of liver fibrosis stages of chronic infection with
hepatitis C virus (HCV) on the in vivo activity of organic cation transporters (hepatic OCT1 …